Adoptive Cell Therapy for Solid Tumors: Current Status in Melanoma and Next-Generation Therapies
John B.A.G. Haanen, Christy Los, Giao Q. Phan, Allison Betof Warner
Abstract
Lifileucel or TIL has recently been FDA approved for metastatic melanoma patients as first cell therapy for a solid tumor. We discuss roll-out of TIL as new SOC and other upcoming new cell therapies.
Topics & Concepts
MelanomaMedicineMetastatic melanomaCell therapySolid tumorOncologyCancer researchInternal medicineCellDermatologyCancerBiologyGeneticsCAR-T cell therapy researchVirus-based gene therapy researchViral Infectious Diseases and Gene Expression in Insects